HEADER CHAPERONE 04-NOV-13 4NH7 TITLE CORRELATION BETWEEN CHEMOTYPE-DEPENDENT BINDING CONFORMATIONS OF HSP90 TITLE 2 ALPHA/BETA AND ISOFORM SELECTIVITY COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEAT SHOCK PROTEIN HSP 90-ALPHA; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 9-236; COMPND 5 SYNONYM: HEAT SHOCK 86 KDA,HSP86,LIPOPOLYSACCHARIDE-ASSOCIATED COMPND 6 PROTEIN 2,LPS-ASSOCIATED PROTEIN 2,RENAL CARCINOMA ANTIGEN NY-REN-38; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HSP90AA1, HSP90A, HSPC1, HSPCA; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS A/B FOLD, CHAPERONE EXPDTA X-RAY DIFFRACTION AUTHOR H.J.ZUCCOLA,J.ERNST REVDAT 3 28-FEB-24 4NH7 1 REMARK REVDAT 2 29-NOV-17 4NH7 1 COMPND SOURCE DBREF SEQADV REVDAT 2 2 1 HET HETNAM HETSYN FORMUL REVDAT 2 3 1 SITE ATOM REVDAT 1 15-JAN-14 4NH7 0 JRNL AUTH J.T.ERNST,M.LIU,H.ZUCCOLA,T.NEUBERT,K.BEAUMONT,A.TURNBULL, JRNL AUTH 2 A.KALLEL,B.VOUGHT,D.STAMOS JRNL TITL CORRELATION BETWEEN CHEMOTYPE-DEPENDENT BINDING JRNL TITL 2 CONFORMATIONS OF HSP90 ALPHA / BETA AND ISOFORM JRNL TITL 3 SELECTIVITY-IMPLICATIONS FOR THE STRUCTURE-BASED DESIGN OF JRNL TITL 4 HSP90 ALPHA / BETA SELECTIVE INHIBITORS FOR TREATING JRNL TITL 5 NEURODEGENERATIVE DISEASES. JRNL REF BIOORG.MED.CHEM.LETT. V. 24 204 2014 JRNL REFN ISSN 0960-894X JRNL PMID 24332488 JRNL DOI 10.1016/J.BMCL.2013.11.036 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.5 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 64.49 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.7 REMARK 3 NUMBER OF REFLECTIONS : 38557 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.208 REMARK 3 R VALUE (WORKING SET) : 0.206 REMARK 3 FREE R VALUE : 0.243 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.030 REMARK 3 FREE R VALUE TEST SET COUNT : 1938 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 19 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.06 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.73 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 3008 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2051 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2864 REMARK 3 BIN R VALUE (WORKING SET) : 0.2036 REMARK 3 BIN FREE R VALUE : 0.2333 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.79 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 144 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3243 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 96 REMARK 3 SOLVENT ATOMS : 264 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 23.31 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 25.42 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.51460 REMARK 3 B22 (A**2) : 2.08040 REMARK 3 B33 (A**2) : -0.56580 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -4.91690 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.161 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.915 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.882 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 3422 ; 1.000 ; HARMONIC REMARK 3 BOND ANGLES : 4623 ; 1.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1240 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 88 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 518 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 3422 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 462 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 4258 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.015 REMARK 3 BOND ANGLES (DEGREES) : 1.41 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.75 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 16.14 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4NH7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-DEC-13. REMARK 100 THE DEPOSITION ID IS D_1000083198. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-JUN-10; 14-JUL-10 REMARK 200 TEMPERATURE (KELVIN) : 100; NULL REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 2 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y; N REMARK 200 RADIATION SOURCE : ALS; NULL REMARK 200 BEAMLINE : 5.0.2; NULL REMARK 200 X-RAY GENERATOR MODEL : NULL; NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M; NULL REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000; NULL REMARK 200 MONOCHROMATOR : DOUBLE-CRYSTAL, SI(111); NULL REMARK 200 OPTICS : NULL; NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD; CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R; ADSC QUANTUM REMARK 200 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : PROCESS REMARK 200 DATA SCALING SOFTWARE : PROCESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 38743 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 64.500 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.8 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.00 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.2 REMARK 200 DATA REDUNDANCY IN SHELL : 3.90 REMARK 200 R MERGE FOR SHELL (I) : 0.40600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH; NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: BUSTER 2.11.5 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 56.53 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.83 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20-25% PEGMME 2000, 100MM CACODYLATE REMARK 280 PH 6.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 57.49000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 44.02000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 57.49000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 44.02000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 4 REMARK 465 SER A 5 REMARK 465 LEU A 6 REMARK 465 HIS A 7 REMARK 465 MET A 8 REMARK 465 ASP A 9 REMARK 465 GLN A 10 REMARK 465 PRO A 11 REMARK 465 MET A 12 REMARK 465 GLU A 13 REMARK 465 GLU A 14 REMARK 465 GLU A 15 REMARK 465 GLU A 16 REMARK 465 GLN A 212 REMARK 465 GLU A 225 REMARK 465 ARG A 226 REMARK 465 ASP A 227 REMARK 465 LYS A 228 REMARK 465 GLU A 229 REMARK 465 VAL A 230 REMARK 465 SER A 231 REMARK 465 ASP A 232 REMARK 465 ASP A 233 REMARK 465 GLU A 234 REMARK 465 ALA A 235 REMARK 465 GLU A 236 REMARK 465 GLY B 4 REMARK 465 SER B 5 REMARK 465 LEU B 6 REMARK 465 HIS B 7 REMARK 465 MET B 8 REMARK 465 ASP B 9 REMARK 465 GLN B 10 REMARK 465 PRO B 11 REMARK 465 MET B 12 REMARK 465 GLU B 13 REMARK 465 GLU B 14 REMARK 465 GLU B 15 REMARK 465 GLU B 16 REMARK 465 GLN B 123 REMARK 465 ALA B 124 REMARK 465 GLY B 125 REMARK 465 GLU B 225 REMARK 465 ARG B 226 REMARK 465 ASP B 227 REMARK 465 LYS B 228 REMARK 465 GLU B 229 REMARK 465 VAL B 230 REMARK 465 SER B 231 REMARK 465 ASP B 232 REMARK 465 ASP B 233 REMARK 465 GLU B 234 REMARK 465 ALA B 235 REMARK 465 GLU B 236 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 38 112.59 -38.38 REMARK 500 ASN A 105 -35.10 -141.82 REMARK 500 ALA A 166 -146.69 60.66 REMARK 500 ARG A 182 137.26 -174.96 REMARK 500 ASN B 105 -54.28 -126.74 REMARK 500 ALA B 166 -142.92 62.87 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HIE A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 304 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HIE B 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B 303 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4NH8 RELATED DB: PDB DBREF 4NH7 A 9 236 UNP P07900 HS90A_HUMAN 131 358 DBREF 4NH7 B 9 236 UNP P07900 HS90A_HUMAN 131 358 SEQADV 4NH7 GLY A 4 UNP P07900 EXPRESSION TAG SEQADV 4NH7 SER A 5 UNP P07900 EXPRESSION TAG SEQADV 4NH7 LEU A 6 UNP P07900 EXPRESSION TAG SEQADV 4NH7 HIS A 7 UNP P07900 EXPRESSION TAG SEQADV 4NH7 MET A 8 UNP P07900 EXPRESSION TAG SEQADV 4NH7 GLY B 4 UNP P07900 EXPRESSION TAG SEQADV 4NH7 SER B 5 UNP P07900 EXPRESSION TAG SEQADV 4NH7 LEU B 6 UNP P07900 EXPRESSION TAG SEQADV 4NH7 HIS B 7 UNP P07900 EXPRESSION TAG SEQADV 4NH7 MET B 8 UNP P07900 EXPRESSION TAG SEQRES 1 A 233 GLY SER LEU HIS MET ASP GLN PRO MET GLU GLU GLU GLU SEQRES 2 A 233 VAL GLU THR PHE ALA PHE GLN ALA GLU ILE ALA GLN LEU SEQRES 3 A 233 MET SER LEU ILE ILE ASN THR PHE TYR SER ASN LYS GLU SEQRES 4 A 233 ILE PHE LEU ARG GLU LEU ILE SER ASN SER SER ASP ALA SEQRES 5 A 233 LEU ASP LYS ILE ARG TYR GLU SER LEU THR ASP PRO SER SEQRES 6 A 233 LYS LEU ASP SER GLY LYS GLU LEU HIS ILE ASN LEU ILE SEQRES 7 A 233 PRO ASN LYS GLN ASP ARG THR LEU THR ILE VAL ASP THR SEQRES 8 A 233 GLY ILE GLY MET THR LYS ALA ASP LEU ILE ASN ASN LEU SEQRES 9 A 233 GLY THR ILE ALA LYS SER GLY THR LYS ALA PHE MET GLU SEQRES 10 A 233 ALA LEU GLN ALA GLY ALA ASP ILE SER MET ILE GLY GLN SEQRES 11 A 233 PHE GLY VAL GLY PHE TYR SER ALA TYR LEU VAL ALA GLU SEQRES 12 A 233 LYS VAL THR VAL ILE THR LYS HIS ASN ASP ASP GLU GLN SEQRES 13 A 233 TYR ALA TRP GLU SER SER ALA GLY GLY SER PHE THR VAL SEQRES 14 A 233 ARG THR ASP THR GLY GLU PRO MET GLY ARG GLY THR LYS SEQRES 15 A 233 VAL ILE LEU HIS LEU LYS GLU ASP GLN THR GLU TYR LEU SEQRES 16 A 233 GLU GLU ARG ARG ILE LYS GLU ILE VAL LYS LYS HIS SER SEQRES 17 A 233 GLN PHE ILE GLY TYR PRO ILE THR LEU PHE VAL GLU LYS SEQRES 18 A 233 GLU ARG ASP LYS GLU VAL SER ASP ASP GLU ALA GLU SEQRES 1 B 233 GLY SER LEU HIS MET ASP GLN PRO MET GLU GLU GLU GLU SEQRES 2 B 233 VAL GLU THR PHE ALA PHE GLN ALA GLU ILE ALA GLN LEU SEQRES 3 B 233 MET SER LEU ILE ILE ASN THR PHE TYR SER ASN LYS GLU SEQRES 4 B 233 ILE PHE LEU ARG GLU LEU ILE SER ASN SER SER ASP ALA SEQRES 5 B 233 LEU ASP LYS ILE ARG TYR GLU SER LEU THR ASP PRO SER SEQRES 6 B 233 LYS LEU ASP SER GLY LYS GLU LEU HIS ILE ASN LEU ILE SEQRES 7 B 233 PRO ASN LYS GLN ASP ARG THR LEU THR ILE VAL ASP THR SEQRES 8 B 233 GLY ILE GLY MET THR LYS ALA ASP LEU ILE ASN ASN LEU SEQRES 9 B 233 GLY THR ILE ALA LYS SER GLY THR LYS ALA PHE MET GLU SEQRES 10 B 233 ALA LEU GLN ALA GLY ALA ASP ILE SER MET ILE GLY GLN SEQRES 11 B 233 PHE GLY VAL GLY PHE TYR SER ALA TYR LEU VAL ALA GLU SEQRES 12 B 233 LYS VAL THR VAL ILE THR LYS HIS ASN ASP ASP GLU GLN SEQRES 13 B 233 TYR ALA TRP GLU SER SER ALA GLY GLY SER PHE THR VAL SEQRES 14 B 233 ARG THR ASP THR GLY GLU PRO MET GLY ARG GLY THR LYS SEQRES 15 B 233 VAL ILE LEU HIS LEU LYS GLU ASP GLN THR GLU TYR LEU SEQRES 16 B 233 GLU GLU ARG ARG ILE LYS GLU ILE VAL LYS LYS HIS SER SEQRES 17 B 233 GLN PHE ILE GLY TYR PRO ILE THR LEU PHE VAL GLU LYS SEQRES 18 B 233 GLU ARG ASP LYS GLU VAL SER ASP ASP GLU ALA GLU HET E0G A 301 33 HET GOL A 302 6 HET GOL A 303 6 HET GOL A 304 6 HET E0G B 301 33 HET GOL B 302 6 HET GOL B 303 6 HETNAM E0G 4-[6,6-DIMETHYL-4-OXIDANYLIDENE-3-(TRIFLUOROMETHYL)-5, HETNAM 2 E0G 7-DIHYDROINDAZOL-1-YL]-2-[(4-OXIDANYLCYCLOHEXYL) HETNAM 3 E0G AMINO]BENZAMIDE HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 E0G 2(C23 H27 F3 N4 O3) FORMUL 4 GOL 5(C3 H8 O3) FORMUL 10 HOH *264(H2 O) HELIX 1 1 GLN A 23 THR A 36 1 14 HELIX 2 2 GLU A 42 LEU A 64 1 23 HELIX 3 3 THR A 65 ASP A 71 5 7 HELIX 4 4 THR A 99 ASN A 105 1 7 HELIX 5 5 ASN A 105 ALA A 124 1 20 HELIX 6 6 ASP A 127 GLY A 135 5 9 HELIX 7 7 VAL A 136 LEU A 143 5 8 HELIX 8 8 GLU A 192 LEU A 198 5 7 HELIX 9 9 GLU A 199 SER A 211 1 13 HELIX 10 10 GLN B 23 THR B 36 1 14 HELIX 11 11 GLU B 42 LEU B 64 1 23 HELIX 12 12 THR B 65 ASP B 71 5 7 HELIX 13 13 THR B 99 ASN B 105 1 7 HELIX 14 14 ASN B 105 LEU B 122 1 18 HELIX 15 15 ASP B 127 GLY B 135 5 9 HELIX 16 16 VAL B 136 LEU B 143 5 8 HELIX 17 17 GLU B 192 LEU B 198 5 7 HELIX 18 18 GLU B 199 SER B 211 1 13 HELIX 19 19 GLN B 212 ILE B 214 5 3 SHEET 1 A 8 GLU A 18 ALA A 21 0 SHEET 2 A 8 SER A 169 THR A 174 -1 O PHE A 170 N PHE A 20 SHEET 3 A 8 GLN A 159 SER A 164 -1 N ALA A 161 O ARG A 173 SHEET 4 A 8 ALA A 145 LYS A 153 -1 N VAL A 150 O TRP A 162 SHEET 5 A 8 GLY A 183 LEU A 190 -1 O ILE A 187 N THR A 149 SHEET 6 A 8 THR A 88 ASP A 93 -1 N ILE A 91 O VAL A 186 SHEET 7 A 8 ILE A 78 ASN A 83 -1 N ASN A 79 O VAL A 92 SHEET 8 A 8 ILE A 218 LEU A 220 1 O THR A 219 N LEU A 80 SHEET 1 B 8 GLU B 18 ALA B 21 0 SHEET 2 B 8 SER B 169 THR B 174 -1 O PHE B 170 N PHE B 20 SHEET 3 B 8 TYR B 160 SER B 164 -1 N GLU B 163 O THR B 171 SHEET 4 B 8 ALA B 145 LYS B 153 -1 N VAL B 150 O TRP B 162 SHEET 5 B 8 GLY B 183 LEU B 190 -1 O ILE B 187 N THR B 149 SHEET 6 B 8 THR B 88 ASP B 93 -1 N ILE B 91 O VAL B 186 SHEET 7 B 8 ILE B 78 ASN B 83 -1 N ILE B 81 O THR B 90 SHEET 8 B 8 ILE B 218 LEU B 220 1 O THR B 219 N LEU B 80 SITE 1 AC1 13 ALA A 55 LYS A 58 ASP A 93 LEU A 107 SITE 2 AC1 13 ALA A 111 GLY A 135 TYR A 139 TRP A 162 SITE 3 AC1 13 THR A 184 GOL A 302 GOL A 304 HOH A 401 SITE 4 AC1 13 HOH A 450 SITE 1 AC2 10 LEU A 107 ILE A 110 E0G A 301 GOL A 304 SITE 2 AC2 10 HOH A 407 HOH A 484 HOH A 511 LYS B 58 SITE 3 AC2 10 TYR B 61 HOH B 410 SITE 1 AC3 7 LYS A 58 HOH A 402 HOH A 418 HOH A 445 SITE 2 AC3 7 E0G B 301 GOL B 303 HOH B 529 SITE 1 AC4 6 ASN A 51 ASP A 54 E0G A 301 GOL A 302 SITE 2 AC4 6 HOH A 478 HOH A 526 SITE 1 AC5 16 GOL A 303 ALA B 55 LYS B 58 ASP B 93 SITE 2 AC5 16 LEU B 107 ALA B 111 GLY B 135 PHE B 138 SITE 3 AC5 16 TYR B 139 TRP B 162 THR B 184 GOL B 302 SITE 4 AC5 16 GOL B 303 HOH B 402 HOH B 404 HOH B 447 SITE 1 AC6 8 GLN B 23 LEU B 103 ILE B 104 TYR B 139 SITE 2 AC6 8 TRP B 162 PHE B 170 E0G B 301 HOH B 406 SITE 1 AC7 6 GOL A 303 ASN B 51 ASP B 54 GLY B 135 SITE 2 AC7 6 E0G B 301 HOH B 529 CRYST1 114.980 88.040 71.070 90.00 124.53 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008697 0.000000 0.005984 0.00000 SCALE2 0.000000 0.011358 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017080 0.00000